FILINGS
AKRO 0001744659 | |||
---|---|---|---|
Filing Date | Form Type | Description | Document |
2024-11-13 | SC 13G/A | AKERO THERAPEUTICS, INC. | View Document |
2024-11-08 | 4 | 4 | View Document |
2024-11-08 | SC 13G/A | SEC SCHEDULE 13G | View Document |
2024-11-08 | 10-Q | 10-Q | View Document |
2024-11-08 | 8-K | 8-K | View Document |
2024-11-06 | 144 | View Document | |
2024-11-05 | 4 | 4 | View Document |
2024-11-05 | 4 | 4 | View Document |
2024-11-01 | 4 | 4 | View Document |
2024-11-01 | 144 | View Document | |
2024-10-18 | 4 | 4 | View Document |
2024-10-17 | SC 13G/A | View Document | |
2024-10-16 | 4 | 4 | View Document |
2024-10-16 | 4 | 4 | View Document |
2024-10-16 | 144 | View Document | |
2024-10-15 | 144 | View Document | |
2024-10-15 | 144 | View Document | |
2024-10-03 | 4 | 4 | View Document |
2024-10-01 | 144 | View Document | |
2024-09-23 | 4 | 4 | View Document |
2024-09-18 | 4 | 4 | View Document |
2024-09-16 | 144 | View Document | |
2024-09-13 | 4 | 4 | View Document |
2024-09-13 | 4 | 4 | View Document |
2024-09-13 | 4 | 4 | View Document |
2024-09-13 | 4 | 4 | View Document |
2024-09-13 | 4 | 4 | View Document |
2024-09-09 | SC 13G/A | SEC SCHEDULE 13G | View Document |
2024-09-05 | 4 | 4 | View Document |
2024-09-05 | 4 | 4 | View Document |
2024-08-29 | 4 | 4 | View Document |
2024-08-28 | 4 | 4 | View Document |
2024-08-26 | 144 | View Document | |
2024-08-23 | 144 | View Document | |
2024-08-20 | 4 | 4 | View Document |
2024-08-09 | 10-Q | 10-Q | View Document |
2024-08-09 | 8-K | 8-K | View Document |
2024-08-02 | 4 | 4 | View Document |
2024-07-25 | 4 | 4 | View Document |
2024-07-24 | 144 | View Document | |
2024-07-18 | 4 | 4 | View Document |
2024-07-16 | 144 | View Document | |
2024-07-02 | 4 | 4 | View Document |
2024-07-02 | 4 | 4 | View Document |
2024-07-02 | 4 | 4 | View Document |
2024-07-02 | 4 | 4 | View Document |
2024-07-02 | 4 | 4 | View Document |
2024-07-01 | 144 | View Document | |
2024-06-13 | 4 | 4 | View Document |
2024-06-13 | 4 | 4 | View Document |
2024-06-13 | 4 | 4 | View Document |
2024-06-13 | 4 | 4 | View Document |
2024-06-13 | 4 | 4 | View Document |
2024-06-13 | 4 | 4 | View Document |
2024-06-12 | 8-K | 8-K | View Document |
2024-06-11 | 4 | 4 | View Document |
2024-06-11 | 4 | 4 | View Document |
2024-06-11 | 4 | 4 | View Document |
2024-06-11 | 4 | 4 | View Document |
2024-06-11 | 4 | 4 | View Document |
2024-06-11 | 4 | 4 | View Document |
2024-06-11 | 4 | 4 | View Document |
2024-06-10 | SC 13G/A | JANUS HENDERSON OWNS 10.1% | View Document |
2024-06-05 | 4 | 4 | View Document |
2024-05-10 | S-3ASR | S-3ASR | View Document |
2024-05-10 | 10-Q | 10-Q | View Document |
2024-05-10 | 8-K | 8-K | View Document |
2024-05-02 | 4 | 4 | View Document |
2024-05-01 | 4 | 4 | View Document |
2024-05-01 | 3 | 3 | View Document |
2024-04-26 | ARS | ARS | View Document |
2024-04-26 | DEF 14A | DEF 14A | View Document |
2024-04-16 | PRE 14A | PRE 14A | View Document |
2024-04-03 | 4 | 4 | View Document |
2024-04-01 | 144 | View Document | |
2024-03-18 | 8-K | 8-K | View Document |
2024-03-15 | 4 | 4 | View Document |
2024-03-15 | 4 | 4 | View Document |
2024-03-15 | 4 | 4 | View Document |
2024-03-15 | 4 | 4 | View Document |
2024-03-15 | 4 | 4 | View Document |
2024-03-15 | SC 13G | SCHEDULE 13G | View Document |
2024-03-06 | 4 | 4 | View Document |
2024-03-06 | 4 | 4 | View Document |
2024-03-06 | 8-K | 8-K | View Document |
2024-03-06 | 424B5 | 424B5 | View Document |
2024-03-05 | 4 | 4 | View Document |
2024-03-04 | 144 | View Document | |
2024-03-04 | 144 | View Document | |
2024-03-04 | 424B5 | 424B5 | View Document |
2024-03-04 | 8-K | 8-K | View Document |
2024-02-29 | S-8 | S-8 | View Document |
2024-02-29 | 10-K | 10-K | View Document |
2024-02-29 | 8-K | 8-K | View Document |
2024-02-14 | SC 13G/A | SC 13G/A | View Document |
2024-02-14 | SC 13G/A | SC 13G/A | View Document |
2024-02-14 | SC 13G/A | SC 13G/A AKERO | View Document |
2024-02-14 | SC 13G | View Document | |
2024-02-14 | SC 13G | AKERO THERAPEUTICS, INC. | View Document |
2024-02-13 | SC 13G/A | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.